Change in macular thickness in a case of refractory diabetic macular edema with dexamethasone intravitreal implant in comparison to intravitreal bevacizumab: A case report

Indian Journal of Ophthalmology

Volumn 60, Issue 3, 2012, Pages 234-235

  Sharma, Ashish ^a   Madhusudhan, Rangasamy J ^a   Nadahalli, Vidhya ^a   Damgude, Shreekant A ^a   Sundaramoorthy, Selva K ^a  

^a Lotus Eye Care Hospital   (India)

Author keywords

Clinically significant macular edema; dexamethasone; implant; ozurdex

Indexed keywords

ANGIOGENESIS INHIBITOR; BEVACIZUMAB; DEXAMETHASONE; GLUCOCORTICOID; MONOCLONAL ANTIBODY; VASCULOTROPIN A;

ADULT; ARTICLE; CASE REPORT; DIABETIC RETINOPATHY; DISEASE COURSE; DRUG ANTAGONISM; DRUG EFFECT; DRUG IMPLANT; FOLLOW UP; HUMAN; INTRAVITREAL DRUG ADMINISTRATION; MALE; OPTICAL COHERENCE TOMOGRAPHY; PATHOLOGY; RETINA MACULA EDEMA; RETINA MACULA LUTEA; VISUAL ACUITY;

ADULT; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; DEXAMETHASONE; DIABETIC RETINOPATHY; DISEASE PROGRESSION; DRUG IMPLANTS; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; INTRAVITREAL INJECTIONS; MACULA LUTEA; MACULAR EDEMA; MALE; TOMOGRAPHY, OPTICAL COHERENCE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY;

EID: 84861327424     PISSN: 03014738     EISSN: 19983689     Source Type: Journal    
DOI: 10.4103/0301-4738.95884     Document Type: Article

References (10)

1. Diabetic Retinopathy Clinical Research Network. A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema. Ophthalmology 2008;115:1447-9.
2. Mehta S, Blinder KJ, Shah GK, Kymes SM, Schlief SL, Grand MG. Intravitreal bevacizumab for the treatment of refractory diabetic macular edema. Ophthalmic Surg Lasers Imaging 2010;41:323-9.
3. Arevalo JF, Fromow-Guerra J, Quiroz-Mercado H, Sanchez JG, Wu L, Maia M, et al. Primary intravitreal bevacizumab (Avastin) for diabetic macular edema: Results from the Pan-American Collaborative Retina Study Group at 6-month follow-up. Ophthalmology 2007;114:743-50.
4. Yilmaz T, Weaver CD, Gallagher MJ, Cordero-Coma M, Cervantes-Castaneda RA, Klisovic D, et al. Intravitreal triamcinolone acetonide injection for treatment of refractory diabetic macular edema: A systematic review. Ophthalmology 2009;116:902-11.
5. Sharma A, Pirouzmanesh A, Andley UP, Kenney MC, Pirouzmanesh A, Kuppermann BD. Evaluation of in-vitro effects of triamcinolone acetonide and dexamethasone on human lens epithelial cells. Paper presented at: The 2008 Association for Research in Vision and Ophthalmology annual meeting; April 27-May 1, 2008; Fort Lauderdale, FL.
6. Kuppermann BD, Patil AJ, Sharma A, Estrago Franco MF, Mansoor S, Raymond V, et al. Effects of triamcinolone acetonide on human trabecular meshwork cells invitro. Paper presented at: the 2008 Association for Research in Vision and Ophthalmology annual meeting; April 27-May 1, 2008; Fort Lauderdale, FL.
7. Myung JS, Aaker GD, Kiss S. Treatment of noninfectious posterior uveitis with dexamethasone intravitreal implant. Clin Ophthalmol 2010;4:1423-6.
8. Haller JA, Bandello F, Belfort R Jr., Blumenkranz MS, Gillies M, Heier J, et al. Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. Ophthalmology 2010;117:1134-46.
9. Nguyen QD, Shah SM, Khwaja AA, Channa R, Hatef E, Do DV, et al. Two-year outcomes of the ranibizumab for edema of the macula in diabetes (READ-2) study. Ophthalmology 2010;117: 2146-51.
10. Massin P, Bandello F, Garweg JG, Hansen LL, Harding SP, Larsen M, et al. Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE Study): A 12-month, randomized, controlled, double-masked, multicenter phase II study. Diabetes Care 2010;33:2399-405.